Literature DB >> 25238642

Circulating rotavirus-specific T cells have a poor functional profile.

Miguel Parra1, Daniel Herrera1, María Fernanda Jácome2, Martha C Mesa2, Luz-Stella Rodríguez1, Carolina Guzmán3, Juana Angel1, Manuel A Franco1.   

Abstract

Frequencies of circulating T cells producing IFN-γ, TNF-α, and IL-2, and percentages of T cells proliferating after stimulation with rotavirus (RV), tetanus toxoid, and influenza were evaluated in PBMC derived from healthy adults and children. In addition, the potential anergic state of RV-specific T cells was analyzed by stimulation of PBMC with RV antigen in the presence of three anergy inhibitors (rIL-2, rIL-12, or DGKα-i). The quality and magnitude of RV-T cell responses were significantly lower than those of tetanus toxoid and influenza antigens. RV-CD4 T cell response was enriched in monofunctional IFN-γ(+) cells, while influenza-CD4 and tetanus toxoid-CD4 T cell responses were enriched in multifunctional T cells. Moreover, rIL-2--unlike rIL-12 or DGKα-i--increased the frequencies of RV-CD4 TNF-α(+), CD4 IFN-γ(+), and CD8 IFN-γ(+) cells. Thus, circulating RV-T cells seem to have a relatively poor functional profile that may be partially reversed in vitro by the addition of rIL-2.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; Proliferation; Rotavirus (RV); T cells

Mesh:

Substances:

Year:  2014        PMID: 25238642     DOI: 10.1016/j.virol.2014.08.020

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  LAP+ Cells Modulate Protection Induced by Oral Vaccination with Rhesus Rotavirus in a Neonatal Mouse Model.

Authors:  Laura María Rey; José Ángel Gil; José Mateus; Luz-Stella Rodríguez; Martín Alonso Rondón; Juana Ángel; Manuel Antonio Franco
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

2.  Immunodeficiency in a Patient with 22q11.2 Distal Deletion Syndrome and a p.Ala7dup Variant in the MAPK1 Gene.

Authors:  Ana I Sánchez; Mary A García-Acero; Angela Paredes; Rossi Quero; Rita I Ortega; Jorge A Rojas; Daniel Herrera; Miguel Parra; Karol Prieto; Juana Ángel; Luz-Stella Rodríguez; Juan C Prieto; Manuel Franco
Journal:  Mol Syndromol       Date:  2020-02-05

Review 3.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

4.  Safety and immunogenicity of a live attenuated pentavalent rotavirus vaccine in HIV-exposed infants with or without HIV infection in Africa.

Authors:  Myron J Levin; Jane C Lindsey; Susan S Kaplan; Werner Schimana; Jody Lawrence; Monica M McNeal; Mutsa Bwakura-Dangarembizi; Anthony Ogwu; Evans M Mpabalwani; Paul Sato; George Siberry; Margaret Nelson; Darcy Hille; Geoffrey A Weinberg; Adriana Weinberg
Journal:  AIDS       Date:  2017-01-02       Impact factor: 4.177

Review 5.  Rotavirus infection.

Authors:  Sue E Crawford; Sasirekha Ramani; Jacqueline E Tate; Umesh D Parashar; Lennart Svensson; Marie Hagbom; Manuel A Franco; Harry B Greenberg; Miguel O'Ryan; Gagandeep Kang; Ulrich Desselberger; Mary K Estes
Journal:  Nat Rev Dis Primers       Date:  2017-11-09       Impact factor: 52.329

6.  Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials.

Authors:  Georgina Bowyer; Tommy Rampling; Jonathan Powlson; Richard Morter; Daniel Wright; Adrian V S Hill; Katie J Ewer
Journal:  Vaccines (Basel)       Date:  2018-07-31

Review 7.  T-Cell Responses after Rotavirus Infection or Vaccination in Children: A Systematic Review.

Authors:  Natasha Makabilo Laban; Martin Rhys Goodier; Samuel Bosomprah; Michelo Simuyandi; Caroline Chisenga; Obvious Nchimunya Chilyabanyama; Roma Chilengi
Journal:  Viruses       Date:  2022-02-23       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.